October 24, 2014 8:52 PM ET

Pharmaceuticals

Company Overview of Intervet, Inc.

Company Overview

Intervet, Inc., a research-driven company, develops, manufactures, and markets veterinary medicines and services for the prevention, treatment, and control of diseases and infections in farm and companion animal species in the United States. The company offers canine influenza vaccine to reduce the severity and spread of canine influenza virus infection; and Innovax-ND, a recombinant vaccine that helps aid in the protection of Newcastle and Marek's diseases in chickens. It is also developing Nobivac Lepto4, a 4-way canine leptospirosis vaccine to prevent clinical diseases, including thrombocytopenia, kidney and liver dysfunction, and leptospiremia in dogs. The company was incorporated in 199...

29160 Intervet Lane

Millsboro, DE 19966-0318

United States

Founded in 1996

Phone:

302-934-4388

Fax:

302-934-4269

Key Executives for Intervet, Inc.

President
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
TOLMAR Therapeutics, Inc. United States
Polaris Pharmaceuticals, Inc. United States
LAXmed United States
Roche Pharma, Inc. United States
LaRon Pharma Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Intervet, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.